Xeris Biopharma (XERS) Q1 2025 Earnings

6MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.14
-0.1
-0.07
-0.03

Details

Expected EPS
-0.055783
Actual EPS
-0.03
Surprise EPS
0.03
Surprise Percent
+46.22%

Description

Xeris Biopharma (XERS) has reported earnings of -0.03 per share for Q1 2025.

0 Comments

Share your thoughts